
Press Room
ArtemiC Phase II Clinical Trial Results
MGC Pharmaceuticals, a partner of Swiss PharmaCan, is currently conducting a clinical trial testing the effectiveness and safety of a MyCell Technology™ -based formulation with respect to COVID-19.
Subscribe to our Newsletter
Be the first to know about the latest news!
MGC Pharmaceuticals, a partner of Swiss PharmaCan, is currently conducting a clinical trial testing the effectiveness and safety of a MyCell Technology™ -based formulation with respect to COVID-19.